HIV quantification: Clinical applications

被引：34

作者：

Volberding, PA

机构：

[1] AIDS Program, San Francisco General Hospital, San Francisco, CA

来源：

LANCET | 1996年 / 347卷 / 8994期

关键词：

D O I：

10.1016/S0140-6736(96)90205-6

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：71 / 73

页数：3

共 16 条

[1] DETECTION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GENOMIC RNA IN PLASMA SAMPLES BY REVERSE-TRANSCRIPTION POLYMERASE CHAIN-REACTION [J].

BAGNARELLI, P ;

MENZO, S ;

MANZIN, A ;

GIACCA, M ;

VARALDO, PE ;

CLEMENTI, M .

JOURNAL OF MEDICAL VIROLOGY, 1991, 34 (02) :89-95

[2] CLINICAL-EVALUATION OF BRANCHED DNA SIGNAL AMPLIFICATION FOR QUANTIFYING HIV TYPE-1 IN HUMAN PLASMA [J].

CAO, YZ ;

HO, DD ;

TODD, J ;

KOKKA, R ;

URDEA, M ;

LIFSON, JD ;

PIATAK, M ;

CHEN, S ;

HAHN, BH ;

SAAG, MS ;

SHAW, GM .

AIDS RESEARCH AND HUMAN RETROVIRUSES, 1995, 11 (03) :353-361

[3]

ERON J, 1995, 2ND NAT C HUM RETR R

[4] A PILOT-STUDY TO EVALUATE THE DEVELOPMENT OF RESISTANCE TO NEVIRAPINE IN ASYMPTOMATIC HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS WITH CD4 CELL COUNTS OF GREATER-THAN-500/MM(3) - AIDS CLINICAL-TRIALS GROUP PROTOCOL-208 [J].

HAVLIR, D ;

MCLAUGHLIN, MM ;

RICHMAN, DD .

JOURNAL OF INFECTIOUS DISEASES, 1995, 172 (05) :1379-1383

[5] HIGH-DOSE NEVIRAPINE - SAFETY, PHARMACOKINETICS, AND ANTIVIRAL EFFECT IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION [J].

HAVLIR, D ;

CHEESEMAN, SH ;

MCLAUGHLIN, M ;

MURPHY, R ;

ERICE, A ;

SPECTOR, SA ;

GREENOUGH, TC ;

SULLIVAN, JL ;

HALL, D ;

MYERS, M ;

LAMSON, M ;

RICHMAN, DD .

JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (03) :537-545

[6] REDUCTION IN PLASMA HUMAN-IMMUNODEFICIENCY-VIRUS RIBONUCLEIC-ACID AFTER DIDEOXYNUCLEOSIDE THERAPY AS DETERMINED BY THE POLYMERASE CHAIN-REACTION [J].

HOLODNIY, M ;

KATZENSTEIN, DA ;

ISRAELSKI, DM ;

MERIGAN, TC .

JOURNAL OF CLINICAL INVESTIGATION, 1991, 88 (05) :1755-1759

[7] DISTINCT CHANGES IN HIV TYPE-1 RNA VERSUS P24 ANTIGEN LEVELS IN SERUM DURING SHORT-TERM ZIDOVUDINE THERAPY IN ASYMPTOMATIC INDIVIDUALS WITH AND WITHOUT PROGRESSION TO AIDS [J].

JURRIAANS, S ;

WEVERLING, GJ ;

GOUDSMIT, J ;

BOOGAARD, J ;

BROK, M ;

VANSTRIJP, D ;

LANGE, J ;

KOOT, M ;

VANGEMEN, B .

AIDS RESEARCH AND HUMAN RETROVIRUSES, 1995, 11 (04) :473-479

[8] MULTICENTER EVALUATION OF QUANTIFICATION METHODS FOR PLASMA HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RNA [J].

LIN, HJ ;

MYERS, LE ;

YENLIEBERMAN, B ;

HOLLINGER, FB ;

HENRARD, D ;

HOOPER, CJ ;

KOKKA, R ;

KWOK, S ;

RASHEED, S ;

VAHEY, M ;

WINTERS, MA ;

MCQUAY, LJ ;

NARA, PL ;

REICHELDERFER, P ;

COOMBS, RW ;

JACKSON, JB .

JOURNAL OF INFECTIOUS DISEASES, 1994, 170 (03) :553-562

[9] PREDICTION OF PROGRESSION TO AIDS WITH SERUM HIV-1 RNA AND CD4 COUNT [J].

LOVEDAY, C ;

HILL, A .

LANCET, 1995, 345 (8952) :790-791

[10]

MELLORS JW, 1995, ANN INTERN MED, V122, P537

← 1 2 →